Back to List/Filter


LOXO-BTK-20030

NCT05254743

A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)
Dunedin Hospital (Haematology)
Dunedin Hospital Great King Street, Central Dunedin, Dunedin, New Zealand
Recruiting
Primary Contact : Cancer & blood trials coordinator Dunedin Hospital, oncresearch@southerndhb.govt.nz , N/A
Waikato Hospital (Haematology)
Pembroke Street, Hamilton West, Hamilton 3204, New Zealand
Closed
Primary Contact : Cancer & blood trials coordinator Waikato, CBRTU-Enquiries@waikatodhb.health.nz , N/A
Western Health (Haematology)
Western Health, Furlong Road, St Albans VIC, Australia
Recruiting
Primary Contact : Heike Raunow, Heike.Raunow@wh.org.au , +613 8395 9167

J2N-OX-JZNU18281

Interventional

Treatment - Drugs

Phase 3

18

100

10/11/2023

N/A

Open

By Specialist and/or Surgeon Referral

Any or not stated

No

No

No
Haematology
Leukaemia (all trials)
Chronic Lymphocytic (CLL)
Newly Diagnosed
Relapsed/Refractory

Myelodysplastic Disorders (MDS)
N/A
N/A

23110009